Sandra M. Lechner, PhD

Executive Director, Biology
Vertex Pharmaceuticals
San Diego, California

Presentation(s):

• Poster Number-49 - Selective Inhibition of NaV1.8 with VX-548 as a Targeted Treatment for Acute Pain

  Poster Abstracts